4 articles
With 12+ patients implanted and mass production planned for 2026, Neuralink's clinical reality is more complicated and more human than the headlines suggest.
The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.
A new partnership between Science Corp and Neurosoft AI aims to dramatically reduce the cost and timeline of brain-computer interface clinical trials through shared infrastructure and software tools.
A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.